Solventum Co. (NYSE:SOLV) Given Consensus Rating of “Hold” by Brokerages

Shares of Solventum Co. (NYSE:SOLV) have earned a consensus rating of “Hold” from the ten research firms that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $68.00.

A number of research firms have weighed in on SOLV. Stifel Nicolaus started coverage on Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price target on the stock. Wolfe Research initiated coverage on Solventum in a research report on Thursday, September 26th. They set a “peer perform” rating on the stock. The Goldman Sachs Group boosted their target price on Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a research note on Monday, August 12th. Morgan Stanley increased their price target on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research note on Monday, November 11th. Finally, Piper Sandler raised their price objective on shares of Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th.

Institutional Trading of Solventum

Institutional investors and hedge funds have recently bought and sold shares of the business. Price T Rowe Associates Inc. MD purchased a new stake in Solventum during the 1st quarter valued at approximately $5,889,000. Mitsubishi UFJ Trust & Banking Corp acquired a new stake in shares of Solventum during the first quarter worth $5,747,000. CWM LLC acquired a new stake in shares of Solventum during the second quarter worth $473,000. Great Valley Advisor Group Inc. acquired a new position in Solventum in the 2nd quarter valued at $493,000. Finally, First Horizon Advisors Inc. purchased a new position in Solventum during the 2nd quarter worth $58,000.

Solventum Price Performance

Solventum stock opened at $71.58 on Thursday. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The company has a fifty day simple moving average of $70.52 and a 200-day simple moving average of $62.35. Solventum has a 12-month low of $47.16 and a 12-month high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.